p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1

Allgayer, 2000, c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems, J. Clin. Oncol., 18, 2201, 10.1200/JCO.2000.18.11.2201 Baselga, 2009, Novel anticancer targets: revisiting ERBB2 and discovering ERBB3, Nat. Rev. Cancer, 9, 463, 10.1038/nrc2656 Bouton, 2001, Functions of the adapter protein Cas: signal convergence and the determination of cellular responses, Oncogene, 20, 6448, 10.1038/sj.onc.1204785 Brabek, 2004, CAS promotes invasiveness of Src-transformed cells, Oncogene, 44, 7406, 10.1038/sj.onc.1207965 Cabodi, 2006, p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis, Cancer Res., 66, 4672, 10.1158/0008-5472.CAN-05-2909 Cabodi, 2010, p130Cas is an essential transducer element in ErbB2 transformation, Faseb J., 10.1096/fj.10-157347 Cukierman, 2001, Taking cell-matrix adhesions to the third dimension, Science, 294, 1708, 10.1126/science.1064829 Debnath, 2003, Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures, Methods, 30, 256, 10.1016/S1046-2023(03)00032-X Defilippi, 2006, p130Cas: a versatile scaffold in signaling networks, Trends Cell Biol., 16, 257, 10.1016/j.tcb.2006.03.003 Deryugina, 2006, Matrix metalloproteinases and tumor metastasis, Cancer Metastasis Rev., 25, 9, 10.1007/s10555-006-7886-9 Desgrosellier, 2010, Integrins in cancer: biological implications and therapeutic opportunities, Nat. Rev. Cancer, 10, 9, 10.1038/nrc2748 Di Stefano, 2007, p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity, Embo J., 26, 2843, 10.1038/sj.emboj.7601724 Graus-Porta, 1995, Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling, Mol. Cell. Biol., 15, 1182, 10.1128/MCB.15.3.1182 Grimsley, 2004, Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration, J. Biol. Chem., 279, 6087, 10.1074/jbc.M307087200 Hay, 2004, Upstream and downstream of mTOR, Genes Dev., 18, 1926, 10.1101/gad.1212704 Holland, 2004, Signaling control of mRNA translation in cancer pathogenesis, Oncogene, 23, 3138, 10.1038/sj.onc.1207590 Honda, 1998, Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas, Nat. Genet., 19, 361, 10.1038/1246 Hsia, 2003, Differential regulation of cell motility and invasion by FAK, J. Cell Biol., 160, 753, 10.1083/jcb.200212114 Hu, 1992, Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors, Mol. Cell. Biol., 12, 981 Hynes, 2005, ERBB receptors and cancer: the complexity of targeted inhibitors, Nat. Rev. Cancer, 5, 341, 10.1038/nrc1609 Hynes, 2009, ErbB receptors and signaling pathways in cancer, Curr. Opin. Cell Biol., 21, 177, 10.1016/j.ceb.2008.12.010 Ignatoski, 2000, ERBB-2 overexpression confers PI 3’ kinase-dependent invasion capacity on human mammary epithelial cells, Br. J. Cancer, 82, 666, 10.1054/bjoc.1999.0979 Inoki, 2002, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling, Nat. Cell Biol., 4, 648, 10.1038/ncb839 Karunagaran, 1996, ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer, Embo J., 15, 254, 10.1002/j.1460-2075.1996.tb00356.x Kelleher, 2004, Translational control by MAPK signaling in long-term synaptic plasticity and memory, Cell, 116, 467, 10.1016/S0092-8674(04)00115-1 King, 2000, p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1), J. Biol. Chem., 275, 41201, 10.1074/jbc.M006553200 Klemke, 1998, CAS/Crk coupling serves as a “molecular switch” for induction of cell migration, J. Cell Biol., 140, 961, 10.1083/jcb.140.4.961 Klos, 2006, ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells, Cancer Res., 66, 2028, 10.1158/0008-5472.CAN-04-4559 Laplante, 2009, mTOR signaling at a glance, J. Cell Sci., 122, 3589, 10.1242/jcs.051011 Lehman, 2002, Molecular crosstalk between p70S6k and MAPK cell signaling pathways, Biochem. Biophys. Res. Commun., 293, 463, 10.1016/S0006-291X(02)00238-3 Li, 2000, Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry, J. Biol. Chem., 275, 14729, 10.1074/jbc.275.19.14729 Ma, 2009, Molecular mechanisms of mTOR-mediated translational control, Nat. Rev. Mol. Cell. Biol., 5, 307, 10.1038/nrm2672 Marcotte, 2009, c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential, Mol. Cell. Biol., 29, 5858, 10.1128/MCB.01731-08 Matsuda, 1990, Binding of transforming protein. P47gag-crk, to a broad range of phosphotyrosine-containing proteins, Science, 248, 1537, 10.1126/science.1694307 Mitra, 2006, Integrin-regulated FAK-Src signaling in normal and cancer cells, Curr. Opin. Cell Biol., 18, 516, 10.1016/j.ceb.2006.08.011 Muller, 1988, Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene, Cell, 54, 105, 10.1016/0092-8674(88)90184-5 Muthuswamy, 2001, ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini, Nat. Cell Biol., 3, 785, 10.1038/ncb0901-785 Nanni, 2000, p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma, Int. J. Cancer, 87, 186, 10.1002/1097-0215(20000715)87:2<186::AID-IJC5>3.0.CO;2-1 Neve, 2002, Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells, Oncogene, 21, 4567, 10.1038/sj.onc.1205555 O’Neill, 2000, Integrin signalling: a new Cas(t) of characters enters the stage, Trends Cell Biol., 10, 111, 10.1016/S0962-8924(99)01714-6 Papakonstanti, 2002, Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganisation, Mol. Biol. Cell, 13, 2946, 10.1091/mbc.02-01-0599 Pearson, 1995, The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain, Embo J., 14, 5279, 10.1002/j.1460-2075.1995.tb00212.x Reynolds, 1989, Stable association of activated pp60src with two tyrosine-phosphorylated cellular proteins, Mol. Cell. Biol., 9, 3951 Riggins, 2003, Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3, J. Biol. Chem., 278, 28264, 10.1074/jbc.M303535200 Saitoh, 2002, Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site, J. Biol. Chem., 277, 20104, 10.1074/jbc.M201745200 Sekulic, 2000, A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells, Cancer Res., 60, 3504 Seton-Rogers, 2004, ErbB2 and TGF-beta: a cooperative role in mammary tumor progression?, Cell Cycle, 5, 597 Sharma, 2009, ErbBs in lung cancer, Exp. Cell Res., 315, 557, 10.1016/j.yexcr.2008.07.026 Slamon, 1989, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science, 244, 707, 10.1126/science.2470152 Spencer, 2000, ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases, J. Cell Biol., 148, 385, 10.1083/jcb.148.2.385 Stupack, 2000, Molecular signaling mechanisms of cell migration and invasion, Immunol. Res., 21, 83, 10.1385/IR:21:2-3:83 Ta, 2008, A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells, Cancer Res., 68, 8796, 10.1158/0008-5472.CAN-08-2426 Thomas, 1993, p70s6k/p85s6k: mechanism of activation, effects of rapamycin and role in mitogenesis, Biochem. Soc. Trans., 21, 901, 10.1042/bst0210901 Tikhmyanova, 2009, CAS proteins in normal and pathological cell growth control, Cell. Mol. Life. Sci. van de Vijver, 2002, A gene-expression signature as a predictor of survival in breast cancer, N. Engl. J. Med., 347, 1999, 10.1056/NEJMoa021967 van der Flier, 2000, Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment, J. Natl. Cancer Inst., 92, 120, 10.1093/jnci/92.2.120 Welch, 2003, Phosphoinositide 3-kinase-dependent activation of Rac, Febs Lett., 546, 93, 10.1016/S0014-5793(03)00454-X Yarden, 2001, Untangling the ErbB signalling network, Nat. Rev. Mol. Cell. Biol., 2, 127, 10.1038/35052073 Yu, 1997, Matrix metalloproteinases. Novel targets for directed cancer therapy, Drugs Aging, 11, 229, 10.2165/00002512-199711030-00006 Zhou, 2006, Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells, Endocrinology, 147, 2557, 10.1210/en.2005-1404